S
Scintillate RCM Healthcare
Free revenue leak check

Stop the silent revenue leaks slowing down your cash flow.

Cash Accelerated. Care Elevated. See where revenue is quietly slipping through your billing in under 2 minutes.

Quick operational check No patient data Instant result first
StopRevenue leakage
StreamlineRevenue cycle
AccelerateCash flow
92 to 38 A/R days. $1.2M recovered. We wish we had called sooner.
Multi-specialty group · $12M practice
01

Find what is slipping

Pinpoint where revenue is most likely getting delayed, denied, underpaid, or written off.

02

See the highest-risk gaps

Get a simple score and the top issues most likely to be costing your team time and money.

03

Know what to fix first

Use the result to decide whether a deeper recovery review is worth pursuing.

Find the revenue leaks your team may not have time to chase.

Answer six practical questions about denials, A/R follow-up, underpayments, documentation, and reporting. You will see your result before we ask for contact information.

0 of 6 answered
Question 01
When claims are denied, how quickly can your team see what caused the denial and who needs to act?
Question 02
How often are coverage, authorization, and required documentation checked before billing problems occur?
Question 03
When claims are denied, how reliably are appeals worked before deadlines are missed?
Question 04
How often does your team catch payer underpayments?
Question 05
How often are documentation gaps caught before they turn into denials?
Question 06
How often does leadership review the numbers that show cash is slowing down?

No patient data needed. This is a fast revenue-cycle check designed to reveal where cash may be delayed, denied, underpaid, or written off.

Your highest-priority leakage indicators

These findings are generated from the six operational answers. They are designed to help decide whether a deeper recovery review is worth the time.

Benchmark context

Benchmarks are not a diagnosis. They help frame why a lightweight review may be worthwhile when visibility, appeal discipline, or variance monitoring is weak.

12%Average denial-rate benchmark used for directional comparison.
84%Potentially avoidable denials in a major industry benchmark.
10%+Denial rate level reported by 41% of providers in recent research.

Optional opportunity sizing

Add specialty and monthly collections only if you want the report to estimate the potential revenue impact more specifically.

Send my detailed findings

Receive the score, priority findings, and recommended next steps for your team.

Thank you. Your request was received.
No patient data. No obligation. Your answers help make the follow-up specific and useful.
Prefer to skip the form? Book a 20-min review now →